128 related articles for article (PubMed ID: 10649274)
1. Treatment of extra-abdominal desmoid tumors with interferon-alpha with or without tretinoin.
Leithner A; Schnack B; Katterschafka T; Wiltschke C; Amann G; Windhager R; Kotz R; Zielinski CC
J Surg Oncol; 2000 Jan; 73(1):21-5. PubMed ID: 10649274
[TBL] [Abstract][Full Text] [Related]
2. Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.
Aviles A; Neri N; Fernandez-Diez J; Silva L; Nambo MJ
Hematology; 2015 Oct; 20(9):538-42. PubMed ID: 25592781
[TBL] [Abstract][Full Text] [Related]
3. Treatment of extra-abdominal aggressive fibromatosis with pegylated interferon.
Stengel G; Metze D; Dörflinger B; Luger TA; Böhm M
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S7-9. PubMed ID: 18625396
[TBL] [Abstract][Full Text] [Related]
4. Surgical excision versus observation as initial management of desmoid tumors: A population based study.
Turner B; Alghamdi M; Henning JW; Kurien E; Morris D; Bouchard-Fortier A; Schiller D; Puloski S; Monument M; Itani D; Mack LA
Eur J Surg Oncol; 2019 Apr; 45(4):699-703. PubMed ID: 30420189
[TBL] [Abstract][Full Text] [Related]
5. Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study.
Oh CR; Jeong H; Kim W; Lee JS; Song SY; Song JS; Cho KJ; Chung HW; Lee MH; Hong JY; Lee J; Kim JE; Ahn JH
Int J Clin Oncol; 2024 Jun; 29(6):853-861. PubMed ID: 38526622
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy in adult desmoid tumors.
Patel SR; Evans HL; Benjamin RS
Cancer; 1993 Dec; 72(11):3244-7. PubMed ID: 8242548
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of prognostic factors affecting recurrences and disease-free survival in extra-abdominal desmoid tumors].
Ozger H; Eralp L; Toker B; Ağaoğlu F; Dizdar Y
Acta Orthop Traumatol Turc; 2007; 41(4):291-4. PubMed ID: 18180559
[TBL] [Abstract][Full Text] [Related]
8. Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis.
van Broekhoven DL; Verhoef C; Elias SG; Witkamp AJ; van Gorp JM; van Geel BA; Wijrdeman HK; van Dalen T
Br J Surg; 2013 Aug; 100(9):1214-9. PubMed ID: 23804156
[TBL] [Abstract][Full Text] [Related]
9. Aggressive fibromatosis in children and adolescents: the Italian experience.
Meazza C; Bisogno G; Gronchi A; Fiore M; Cecchetto G; Alaggio R; Milano GM; Casanova M; Carli M; Ferrari A
Cancer; 2010 Jan; 116(1):233-40. PubMed ID: 19950127
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of escalating doses of intravesical interferon alpha-2b in reducing recurrence rate and progression in superficial transitional cell carcinoma.
Giannakopoulos S; Gekas A; Alivizatos G; Sofras F; Becopoulos T; Dimopoulos C
Br J Urol; 1998 Dec; 82(6):829-34. PubMed ID: 9883220
[TBL] [Abstract][Full Text] [Related]
11. Chest-wall desmoid tumors: results of surgical intervention.
Abbas AE; Deschamps C; Cassivi SD; Nichols FC; Allen MS; Schleck CD; Pairolero PC
Ann Thorac Surg; 2004 Oct; 78(4):1219-23; discussion 1219-23. PubMed ID: 15464474
[TBL] [Abstract][Full Text] [Related]
12. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
[TBL] [Abstract][Full Text] [Related]
13. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
Chamberlain MC; Glantz MJ
Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
[TBL] [Abstract][Full Text] [Related]
14. Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon.
Ascierto PA; Daponte A; Parasole R; Perrone F; Caracò C; Melucci M; Palmieri G; Napolitano M; Mozzillo N; Castello G
Cancer; 2000 Oct; 89(7):1490-4. PubMed ID: 11013362
[TBL] [Abstract][Full Text] [Related]
15. Sporadic Abdominal Wall Desmoid type Fibromatosis: treatment paradigm after thirty two years.
Couto Netto SD; Teixeira F; Menegozzo CAM; Leão-Filho HM; Albertini A; Ferreira FO; Akaishi EH; Utiyama EM
BMC Surg; 2018 Jun; 18(1):37. PubMed ID: 29879959
[TBL] [Abstract][Full Text] [Related]
16. Oral vinorelbine in young patients with desmoid-type fibromatosis.
Kornreich L; Orbach D; Nicolas N; Brisse HJ; Berlanga P; Defachelles AS; Mansuy L; Verite C; Saumet L; Karanian M; Corradini N
Tumori; 2023 Oct; 109(5):511-518. PubMed ID: 37114926
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy for desmoid tumors.
Okuno SH; Edmonson JH
Cancer; 2003 Feb; 97(4):1134-5. PubMed ID: 12569616
[TBL] [Abstract][Full Text] [Related]
18. [Extra-abdominal desmoid tumors: 7-year outcome after surgical treatment in 12 patients].
Ayadi K; Trigui M; Zribi M; Keskes H
Rev Chir Orthop Reparatrice Appar Mot; 2003 Sep; 89(5):385-92. PubMed ID: 13679736
[TBL] [Abstract][Full Text] [Related]
19. Desmoid tumors in patients with familial adenomatous polyposis.
Rodriguez-Bigas MA; Mahoney MC; Karakousis CP; Petrelli NJ
Cancer; 1994 Aug; 74(4):1270-4. PubMed ID: 7519966
[TBL] [Abstract][Full Text] [Related]
20. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
